Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Moxidectin: Macrocyclic Lactone Anthelmintic for Antifungal
2026-05-19
Moxidectin is a macrocyclic lactone anthelmintic now validated for both parasitic worm control and as an enhancer of antifungal polyene efficacy. Robust mechanistic studies highlight its role in potentiating polyene antifungals against Candida albicans by elevating ergosterol biosynthesis. High-purity moxidectin products, such as APExBIO’s B3611, enable reproducible translational research and protocol optimization.
-
ML-7 Hydrochloride: Precision Myosin Light Chain Kinase Inhi
2026-05-18
ML-7 hydrochloride empowers researchers to dissect myosin light chain kinase pathways with high specificity, enabling breakthroughs in cardiovascular, cancer, and vascular research models. Discover advanced workflows, troubleshooting strategies, and the latest translational insights that set this myosin light chain kinase inhibitor apart.
-
PRC2 Recruitment in Chromatin: DNA Linker Dominance and RNA
2026-05-18
This article examines the molecular mechanisms of PRC2 recruitment to chromatin, emphasizing the dominance of protein-free linker DNA over histone modifications and the mutually exclusive inhibition of PRC2 by RNA. The findings refine models of epigenetic gene silencing and inform future experimental designs for chromatin studies.
-
(+)-Bicuculline: Protocol Guidance for GABAA Antagonist Assa
2026-05-17
(+)-Bicuculline is used to interrogate GABAA receptor-mediated inhibitory neurotransmission and synaptic NMDA receptor signaling in neuroscience research. Proper handling and solution preparation are essential for reproducible experimental results. This reagent is not intended for diagnostic, therapeutic, or clinical applications.
-
Cefazedone (Refosporen): Atomic Data & Clinical Integration
2026-05-16
Cefazedone (Refosporen) is a first-generation cephalosporin antibiotic with robust, β-lactamase-resistant activity against key Gram-positive and Gram-negative pathogens. Its mechanism, pharmacokinetics, and clinical benchmarks enable reliable use in antibacterial testing and treatment of community-acquired pneumonia.
-
Disrupting c-MYC-G9a Axis to Suppress Breast Tumorigenesis
2026-05-15
This study demonstrates that co-targeting BRD4 and RAC1 disrupts the c-MYC-G9a-FTH1 axis and downregulates HDAC1, leading to suppression of growth, stemness, and tumorigenic potential in distinct breast cancer subtypes. These findings advance understanding of epigenetic regulation in oncogenic pathways and highlight new therapeutic strategies for aggressive breast cancers.
-
Busulfan: DNA Alkylating Agent for Germ Cell and Senescence
2026-05-15
Busulfan’s unique DNA crosslinking capability enables precise senescence induction in WI38 fibroblasts and robust germ cell depletion in mouse models. This guide delivers optimized workflows, troubleshooting insights, and protocol refinements inspired by cutting-edge dual recombinase tracing studies, positioning Busulfan from APExBIO as a cornerstone reagent for reproductive and cellular aging research.
-
CAPE Inhibits C. difficile Toxins and Modulates Gut Microbio
2026-05-14
Guo et al. (2025) identify caffeic acid phenethyl ester (CAPE) as an inhibitor of the TcdB toxin in Clostridioides difficile, demonstrating direct toxin binding and microbiota modulation in a murine infection model. This work advances the antivirulence paradigm for CDI and provides mechanistic insights relevant to anti-infection research.
-
Doxycycline in Research: Optimizing Tetracycline Antibiotic
2026-05-14
APExBIO’s Doxycycline empowers precision research as a dual-action tetracycline antibiotic, uniquely bridging antimicrobial and antiproliferative assays. Explore evidence-based workflows, nanoparticle delivery advances, and troubleshooting tips to maximize its impact in cancer and vascular disease models.
-
Puerarin Drives Osteogenic Differentiation via Nitric Oxide
2026-05-13
This study demonstrates that puerarin significantly enhances the osteogenic differentiation of rat dental follicle cells (rDFCs) by activating the nitric oxide (NO) signaling pathway. The work highlights the mechanistic role of NO in periodontal regeneration and offers reproducible models for investigating NOS pathway modulation in dental tissue engineering.
-
Phenylmethanesulfonyl Fluoride (PMSF): Beyond Protease Inhib
2026-05-13
Explore the advanced roles of phenylmethanesulfonyl fluoride (PMSF) in serine protease inhibition and its impact on high-fidelity cell signaling studies. This article uniquely bridges biochemical specificity with translational assay design, offering technical insights for optimizing biomedical workflows.
-
Doxycycline Applications: From AAA Modeling to Cancer Resear
2026-05-12
Doxycycline, a tetracycline antibiotic, is transforming research through its dual roles as a broad-spectrum antimicrobial and potent metalloproteinase inhibitor. Recent advances in delivery—exemplified by targeted nanoparticle systems—unlock new levels of precision for disease modeling and therapeutic studies. This guide breaks down experimental workflows, practical troubleshooting, and innovative use-cases for maximizing the impact of Doxycycline in preclinical research.
-
Deferiprone for Iron Modulation: Applied Workflows and Optim
2026-05-12
Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) is a versatile iron chelator that enables precise control of iron-dependent pathways in cancer, metabolic, and neurovascular research. This article distills the latest reference findings and hands-on workflow strategies to unlock reproducibility and advanced assay performance with APExBIO’s Deferiprone.
-
Quantitative In Vitro Assessment of Cancer Drug Responses
2026-05-11
Schwartz's dissertation advances in vitro drug response evaluation by dissecting growth inhibition and cell death metrics in cancer models. This work clarifies the nuanced effects of anti-cancer agents like PLK1 inhibitors and informs rigorous assay selection for translational research.
-
Single-Molecule Imaging Reveals Bidirectional DNA Replicatio
2026-05-11
This study by Terui et al. leverages single-molecule imaging to elucidate the precise sequence and dynamics of protein recruitment during bidirectional DNA replication initiation in metazoans. The findings clarify the orchestration of replication firing factors and highlight the ATPase activity of RecQL4 as essential for efficient origin activation, informing future mechanistic and structural research.